The Application Notebook
An ultrafast gradient LC separation method was developed to separate a 5-component drug mixture in 30 seconds, with peak widths of 1 second. maXis mass accuracy at sub-ppm levels and true isotopic pattern of the spectra from the peaks lead to a confident elemental formula assignment for each drug compound with the SmartFormula algorithm.
Catherine Stacey, Sebastian Goetz and Carsten Baessmann, Bruker Daltonik GmbH, Bremen, Germany.
An ultrafast gradient LC separation method was developed to separate a 5-component drug mixture in 30 seconds, with peak widths of 1 second. maXis mass accuracy at sub-ppm levels and true isotopic pattern of the spectra from the peaks lead to a confident elemental formula assignment for each drug compound with the SmartFormula algorithm.
Modern discovery applications demand definitive MS results on ever more complex samples. maXis is the only mass spectrometer able to deliver the maximum MS performance specification at the very highest speeds made available by modern ultrafast liquid chromatography. Here, a complete gradient LC separation of typical drug molecules is achieved in 30 seconds, with each component detected with sub-ppm mass accuracy.
Figure 1
A drug mixture (norharmane, sulphamethazine, sulphamethoxazole, oxybutynin and terfenadine) was separated by an ultrafast separation LC (U-HPLC) using a flow-rate of 0.5 mL/min and a gradient from 4% acetonitrile to 95% acetonitrile in 0.5 mins. The maXis electrospray LC–MS dataset was acquired with an acquisition rate of 10 Hz. The dataset was automatically recalibrated in the Compass DataAnalysis 4.0 processing software with several masses of salt clusters resulting from a loop injection of lithium formate solution (10 mM in water/isopropanol) at the end of the separation.
Figure 2
The separation of the 5 drug mix gave baseline resolution of each compound within 30 seconds (Figure 1). For each peak more than 15 spectral measurements were made across each peak, to give reproducible peak areas suitable for quantitative analysis (Figure 2). In the mass spectrum, the mass accuracy for each peak of the isotopes is below 1 ppm, with a resolution of 43700 — acquired at an acquisition rate of 10 Hz (Figure 3). SmartFormula analysis is automated in the Compass 1.3 data processing software. SmartFormula automatically determines the possible elemental compositions of each compound LC peak, using a mass accuracy of < 2 ppm error with allowed chemical rules and elements (CnHnNnOnSn). Formulae are ranked according to the closest match factor between the measured isotopic pattern and the theoretical pattern for a given formula — the Sigma value, which should be close to zero. For these drug compounds, a unique SmartFormula result was produced within the allowed mass accuracy and Sigma values (Figure 4). Peak 4, Oxybutynin (Figure 5) was unequivocally confirmed in this experiment.
Figure 3
The maXis is an ideal instrument for maximum MS performance at the very highest speeds delivered by modern ultrafast chromatography. Sub-ppm mass accuracy is shown for small molecule drugs, together with a resolution in excess of 40000. Thus the instrument allows extraction of full quantitative information from high speed chromatography. Supported by SmartFormula, the maXis provides unequivocal molecular formula determination capabilities. For compounds with higher molecular weight (up to 1000 Da) SmartFormula 3D is using MS–MS fragment data for certainty in small molecule identifications.1
Figure 4
For research use only. Not for use in diagnostic procedures.
1. Bruker Daltonics Technical Note-23, "Certainty in Small Molecule Identification by Applying SmartFormula 3D on a UHR-TOF Mass Spectrometer."
Bruker Daltonik GmbH
Fahrenheitstr. 4, 28359 Bremen, Germany
tel. +49 421 2205 0 fax +49 421 2205 104
E-mail: sales@bdal.de
Website: www.bdal.com
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
GPCRs – The Biological Traffic Modulator: Chromatographic Analysis of Peptides in the GI Tract
January 20th 2025The G protein-coupled receptors (GPCR) are found throughout the entire body and have shown significance in the development of new therapeutic treatments. Isolation of seven classic GRPC peptides initiating in the GI tract highlights the benefits of using the polymer-based PRP-3, a reversed-phase resin. The covalent bonds found in the PRP-3 exhibit advantageous interactions between the biological π bonds found in the peptides and the available aromatic benzyl rings of the resin.